About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

FIT Combining FC for Predicting MH and Histology Remission in UC

NCT05447572·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Yan Zhang, DOC
CONTACT
+86-18560089821 qlzhangyan@qq.com
Yihao Song, DOC
CONTACT
+86-13165133773 781975756@qq.com

Lead

Shandong University

Age

Any age

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Ulcerative colitis patients.

You may not be if

GI bleeding

The record

StatusUnknown

PhaseNo phase

Taking part300

StartedSep 2021

UpdatedNov 15, 2022

Conditions

Ulcerative Colitis Histology Remission Fecal Calprotetin FIT Mucosal Healing

Where1

Qilu hospital of Shandong University
Jinan, Shandong, China

Clareo Health | FIT Combining FC for Predicting MH and Histology Remission in UC